Should we look beyond the interferon signature in chilblain-like lesions associated with COVID-19?

S M Pilkington; R E B Watson

doi:10.1111/bjd.20784

Should we look beyond the interferon signature in chilblain-like lesions associated with COVID-19?

Division of Musculoskeletal & Dermatological Sciences (L5)

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	1090-1091
Number of pages	2
Journal	The British journal of dermatology
Volume	185
Issue number	6
DOIs	https://doi.org/10.1111/bjd.20784
Publication status	Published - Dec 2021

Keywords

Antiviral Agents
COVID-19
Chilblains/diagnosis
Humans
Interferons
SARS-CoV-2

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/bjd.20784

Cite this

@article{7f9d007b5fb94d4a9684058917717c50,

title = "Should we look beyond the interferon signature in chilblain-like lesions associated with COVID-19?",

keywords = "Antiviral Agents, COVID-19, Chilblains/diagnosis, Humans, Interferons, SARS-CoV-2",

author = "Pilkington, {S M} and Watson, {R E B}",

year = "2021",

month = dec,

doi = "10.1111/bjd.20784",

language = "English",

volume = "185",

pages = "1090--1091",

journal = "The British journal of dermatology",

issn = "0007-0963",